MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits

Nature Communications

Volumn 5, Issue , 2014, Pages

  Zhou, Xikun ^a,b   Li, Xuefeng ^a,b   Ye, Yan ^a   Zhao, Kelei ^a   Zhuang, Yan ^a   Li, Yi ^a,b   Wei, Yuquan ^b   Wu, Min ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MICRORNA; MICRORNA 302B; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; DACTINOMYCIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK4 PROTEIN, MOUSE;

BACTERIUM; BLOOD; CELLS AND CELL COMPONENTS; DEFENSE BEHAVIOR; IMMUNE RESPONSE; INFECTIOUS DISEASE; PATHOLOGY; PHYSIOLOGICAL RESPONSE; PROTEIN; RNA; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION SYSTEM; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DACTINOMYCIN; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MICROSCOPY, CONFOCAL; PSEUDOMONAS AERUGINOSA; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84904053158     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4619     Document Type: Article

References (69)

1. O'Riordan, M., Yi, C. H., Gonzales, R., Lee, K. D. & Portnoy, D. A. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl Acad. Sci. USA 99, 13861-13866 (2002).
2. Coburn, J. & Frank, D. W. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 67, 3151-3154 (1999).
3. Yuan, K. et al. Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages. J. Cell. Sci. 125, 507-515 (2012).
4. Sun, H. Y., Fujitani, S., Quintiliani, R. & Yu, V. L. Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. Chest 139, 1172-1185 (2011).
5. Chu, H. & Mazmanian, S. K. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat. Immunol. 14, 668-675 (2013).
6. Kumar, H. & Bot, A. Innate immune recognition mechanisms and translational opportunities. Int. Rev. Immunol. 32, 113-115 (2013).
7. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
8. Farh, K. K. et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817-1821 (2005).
9. Pillai, R. S., Bhattacharyya, S. N. & Filipowicz, W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell. Biol. 17, 118-126 (2007).
10. Djuranovic, S., Nahvi, A. & Green, R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237-240 (2012).
11. Yates, L. A., Norbury, C. J. & Gilbert, R. J. The long and short of microRNA. Cell 153, 516-519 (2013).
12. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144 (2006).
13. Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010).
14. Zhu, S. et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat. Med. 18, 1077-1086 (2012).
15. Foster, P. S. et al. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol. Rev. 253, 198-215 (2013).
16. O'Connell, R. M., Rao, D. S. & Baltimore, D. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30, 295-312 (2012).
17. Zhou, H. et al. miR-155 and its star-form partner miR-155∗ cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116, 5885-5894 (2010).
18. Shaked, I. et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31, 965-973 (2009).
19. Ceppi, M. et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl Acad. Sci. USA 106, 2735-2740 (2009).
20. Nahid, M. A., Satoh, M. & Chan, E. K. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186, 1723-1734 (2011).
21. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486 (2006).
22. Boldin, M. P. et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201 (2011).
23. Hou, J. et al. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183, 2150-2158 (2009).
24. Nahid, M. A. et al. Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J. Immunol. 190, 1250-1263 (2013).
25. Bushati, N. & Cohen, S. M. microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205 (2007).
26. Lorenz, E. TLR2 and TLR4 expression during bacterial infections. Curr. Pharm. Des. 12, 4185-4193 (2006).
27. Li, G. et al. Lyn mitigates mouse airway remodeling by downregulating the TGF-beta3 isoform in house dust mite models. J. Immunol. 191, 5359-5370 (2013).
28. Guo, Q. et al. Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity. Eur. J. Immunol. 42, 1500-1511 (2012).
29. Wu, M. et al. Host DNA repair proteins in response to Pseudomonas aeruginosa in lung epithelial cells and in mice. Infect. Immun. 79, 75-87 (2011).
30. Lee, M. S. & Kim, Y. J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447-480 (2007).
31. Yuan, K. et al. Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice. Gastroenterology 145, 853-864 e859 (2013).
32. Manni, M. L. et al. Extracellular superoxide dismutase in macrophages augments bacterial killing by promoting phagocytosis. Am. J. Pathol. 178, 2752-2759 (2011).
33. Caamano, J. & Hunter, C. A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15, 414-429 (2002).
34. John, B. et al. Human MicroRNA targets. PLoS Biol. 2, e363 (2004).
35. Kim, T. W. et al. A critical role for IRAK4 kinase activity in Toll-like receptormediated innate immunity. J. Exp. Med. 204, 1025-1036 (2007).
36. Cuschieri, J., Billigren, J. & Maier, R. V. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation. J. Leukoc. Biol. 80, 1289-1297 (2006).
37. Nomura, F. et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164, 3476-3479 (2000).
38. Kuo, C. H., Deng, J. H., Deng, Q. & Ying, S. Y. A novel role of miR-302/367 in reprogramming. Biochem. Biophys. Res. Commun. 417, 11-16 (2012).
39. Kurowska-Stolarska, M. et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl Acad. Sci. USA 108, 11193-11198 (2011).
40. Tang, Y. et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60, 1065-1075 (2009).
41. Cario, E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm. Bowel Dis. 16, 1583-1597 (2010).
42. Plata-Salaman, C. R., Ilyin, S. E., Gayle, D. & Flynn, M. C. Gram-negative and gram-positive bacterial products induce differential cytokine profiles in the brain: analysis using an integrative molecular-behavioral in vivo model. Int. J. Mol. Med. 1, 387-397 (1998).
43. Asimakopoulos, G., Smith, P. L., Ratnatunga, C. P. & Taylor, K. M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann. Thorac. Surg. 68, 1107-1115 (1999).
44. Liu, X., Chen, W., Wang, Q., Li, L. & Wang, C. Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6. PLoS Pathog. 9, e1003480 (2013).
45. Yuk, J. M. et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat. Immunol. 12, 742-751 (2011).
46. O'Neill, L. A. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29, 12-20 (2008).
47. Ajibade, A. A. et al. TAK1 negatively regulates NF-kappaB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Immunity 36, 43-54 (2012).
48. Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S. & Taganov, K. D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839-845 (2008).
49. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604-1609 (2007).
50. Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885-890 (2010).
51. Jiang, Z., Ninomiya-Tsuji, J., Qian, Y., Matsumoto, K. & Li, X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 22, 7158-7167 (2002).
52. Qian, Y., Commane, M., Ninomiya-Tsuji, J., Matsumoto, K. & Li, X. IRAKmediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B. J. Biol. Chem. 276, 41661-41667 (2001).
53. Deng, L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
54. Lye, E., Dhanji, S., Calzascia, T., Elford, A. R. & Ohashi, P. S. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses. Eur. J. Immunol. 38, 870-876 (2008).
55. Subramanyam, D. et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29, 443-448 (2011).
56. Kang, H. et al. Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J. Biol. Chem. 287, 38656-38664 (2012).
57. Wang, Y. et al. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat. Genet. 40, 1478-1483 (2008).
58. Fareh, M. et al. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell. Death Differ. 19, 232-244 (2012).
59. Lin, S. L. et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14, 2115-2124 (2008).
60. Lin, S.-L. et al. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 39, 1054-1065 (2011).
61. Melton, C., Judson, R. L. & Blelloch, R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463, 621-626 (2010).
62. El Gazzar, M., Church, A., Liu, T. & McCall, C. E. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J. Leukoc. Biol. 90, 509-519 (2011).
63. Domingo-Gonzalez, R. et al. Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant. J. Immunol. 190, 5809-5817 (2013).
64. Vergadi, E. et al. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J. Immunol. 192, 394-406 (2014).
65. Kulesekara, H. et al. Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3′-5′)-cyclic-GMP in virulence. Proc. Natl Acad. Sci. USA 103, 2839-2844 (2006).
66. Priebe, G. P. et al. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infect. Immun. 70, 1507-1517 (2002).
67. Lawlor, M. S., Hsu, J., Rick, P. D. & Miller, V. L. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol. Microbiol. 58, 1054-1073 (2005).
68. Yuan, K. et al. Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB). J. Biol. Chem. 286, 21814-21825 (2011).
69. Kim, S. W. et al. A sensitive non-radioactive northern blot method to detect small RNAs. Nucleic Acids Res. 38, e98 (2010).